Boston Scientific Plans 2008 Post-Warning Letter Interventional Launches
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific plans to launch four new interventional cardiology products in 2008 after resolving a two-and-a-half-year-old company-wide FDA warning letter